Cleararc Capital Inc. decreased its position in Cardinal Health, Inc. (NYSE:CAH) by 0.7% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 8,913 shares of the company’s stock after selling 60 shares during the period. Cleararc Capital Inc.’s holdings in Cardinal Health were worth $641,000 as of its most recent filing with the SEC.
Several other large investors have also added to or reduced their stakes in the company. Quadrant Capital Group LLC boosted its stake in Cardinal Health by 2.4% in the third quarter. Quadrant Capital Group LLC now owns 1,906 shares of the company’s stock worth $142,000 after buying an additional 44 shares during the last quarter. SRB Corp boosted its stake in shares of Cardinal Health by 4.6% in the third quarter. SRB Corp now owns 1,914 shares of the company’s stock worth $149,000 after buying an additional 84 shares in the last quarter. Acrospire Investment Management LLC boosted its stake in shares of Cardinal Health by 150.0% in the third quarter. Acrospire Investment Management LLC now owns 2,000 shares of the company’s stock worth $155,000 after buying an additional 1,200 shares in the last quarter. Alpha Windward LLC boosted its stake in shares of Cardinal Health by 0.8% in the third quarter. Alpha Windward LLC now owns 2,133 shares of the company’s stock worth $166,000 after buying an additional 16 shares in the last quarter. Finally, Global X Management Co. LLC boosted its stake in shares of Cardinal Health by 241.2% in the third quarter. Global X Management Co. LLC now owns 2,146 shares of the company’s stock worth $167,000 after buying an additional 1,517 shares in the last quarter. Institutional investors own 85.84% of the company’s stock.
Cardinal Health, Inc. (NYSE:CAH) opened at 80.24 on Friday. The stock has a market cap of $25.31 billion, a price-to-earnings ratio of 19.32 and a beta of 0.71. The firm’s 50-day moving average price is $75.48 and its 200-day moving average price is $75.62. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $87.85.
Cardinal Health (NYSE:CAH) last released its earnings results on Tuesday, February 7th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.11. Cardinal Health had a return on equity of 25.52% and a net margin of 1.06%. The firm had revenue of $33.10 billion for the quarter, compared to analysts’ expectations of $33.63 billion. During the same period in the prior year, the firm posted $1.30 earnings per share. The company’s quarterly revenue was up 5.4% on a year-over-year basis. On average, equities analysts predict that Cardinal Health, Inc. will post $5.42 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Saturday, April 15th. Stockholders of record on Monday, April 3rd will be paid a $0.4489 dividend. The ex-dividend date of this dividend is Thursday, March 30th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.24%. Cardinal Health’s dividend payout ratio is currently 43.17%.
This article was published by sleekmoney and is owned by of sleekmoney. If you are reading this article on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The original version of this article can be accessed at http://sleekmoney.com/cardinal-health-inc-cah-stake-lowered-by-cleararc-capital-inc/1666194.html.
A number of brokerages recently issued reports on CAH. Vetr cut Cardinal Health from a “buy” rating to a “hold” rating and set a $76.99 price objective on the stock. in a research note on Tuesday, January 3rd. Zacks Investment Research cut Cardinal Health from a “hold” rating to a “sell” rating in a research note on Friday, February 10th. Leerink Swann set a $81.00 price objective on Cardinal Health and gave the company a “hold” rating in a research note on Wednesday, February 8th. Mizuho cut Cardinal Health from a “buy” rating to a “neutral” rating and set a $79.00 price objective on the stock. in a research note on Tuesday, January 3rd. Finally, Barclays PLC set a $88.00 price objective on Cardinal Health and gave the company a “buy” rating in a research note on Monday, November 14th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and five have assigned a buy rating to the company. Cardinal Health currently has an average rating of “Hold” and a consensus target price of $88.54.
In other news, Chairman George S. Barrett sold 217,994 shares of the stock in a transaction on Friday, February 10th. The stock was sold at an average price of $77.23, for a total value of $16,835,676.62. Following the sale, the chairman now directly owns 682,225 shares of the company’s stock, valued at $52,688,236.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.94% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/cardinal-health-inc-cah-stake-lowered-by-cleararc-capital-inc/1666194.html
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.